243
Participants
Start Date
October 31, 2016
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2020
Simmitecan
5-fluorouracil and Leucovorin Calcium
Thalidomide
NOT_YET_RECRUITING
The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou
RECRUITING
Beijing Cancer Hospital, Beijin
NOT_YET_RECRUITING
The first hospital of China Medical University, Shenyang
NOT_YET_RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
NOT_YET_RECRUITING
Tianjin Cancer Hospital, Tianjin
NOT_YET_RECRUITING
Hunan Cancer Hospital, Changsha
NOT_YET_RECRUITING
Tongji Hospital of Tongji Medical College,Huazhong University of Science and Technology, Wuhan
NOT_YET_RECRUITING
Harbin Medical University Cancer Hospital, Harbin
NOT_YET_RECRUITING
Jiangsu Cancer Hospital, Nanjing
Lead Sponsor
Haihe Biopharma Co., Ltd.
INDUSTRY